PL1653994T3 - Zastosowanie chemokiny CXCL6 w profilaktyce lub naprawie ubytków chrząstki - Google Patents

Zastosowanie chemokiny CXCL6 w profilaktyce lub naprawie ubytków chrząstki

Info

Publication number
PL1653994T3
PL1653994T3 PL04761478T PL04761478T PL1653994T3 PL 1653994 T3 PL1653994 T3 PL 1653994T3 PL 04761478 T PL04761478 T PL 04761478T PL 04761478 T PL04761478 T PL 04761478T PL 1653994 T3 PL1653994 T3 PL 1653994T3
Authority
PL
Poland
Prior art keywords
repair
cxcl6
prevention
cartilage
cartilage defects
Prior art date
Application number
PL04761478T
Other languages
English (en)
Inventor
Frank Luyten
Bari Cosimo De
Francesco Dell'accio
Original Assignee
Tigenix Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34135345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1653994(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tigenix Nv filed Critical Tigenix Nv
Publication of PL1653994T3 publication Critical patent/PL1653994T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL04761478T 2003-08-12 2004-08-12 Zastosowanie chemokiny CXCL6 w profilaktyce lub naprawie ubytków chrząstki PL1653994T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49451603P 2003-08-12 2003-08-12
EP04761478A EP1653994B1 (en) 2003-08-12 2004-08-12 Use of cxcl6 chemokine in the prevention or repair of cartilage defects
PCT/BE2004/000117 WO2005014026A2 (en) 2003-08-12 2004-08-12 Use of cxcl6 chemokine in the prevention or repair of cartilage defects

Publications (1)

Publication Number Publication Date
PL1653994T3 true PL1653994T3 (pl) 2010-05-31

Family

ID=34135345

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04761478T PL1653994T3 (pl) 2003-08-12 2004-08-12 Zastosowanie chemokiny CXCL6 w profilaktyce lub naprawie ubytków chrząstki

Country Status (15)

Country Link
US (2) US7485310B2 (pl)
EP (1) EP1653994B1 (pl)
JP (1) JP4920412B2 (pl)
AT (1) ATE449608T1 (pl)
AU (1) AU2004262451B2 (pl)
CA (1) CA2533124C (pl)
DE (1) DE602004024312D1 (pl)
DK (1) DK1653994T3 (pl)
ES (1) ES2337469T3 (pl)
IL (1) IL173544A (pl)
NO (1) NO338152B1 (pl)
NZ (1) NZ545702A (pl)
PL (1) PL1653994T3 (pl)
RU (1) RU2363491C2 (pl)
WO (1) WO2005014026A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US20050222687A1 (en) * 2004-04-02 2005-10-06 Gordana Vunjak-Novakovic Cartilage implant assembly and method for implantation
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US20090291112A1 (en) * 2003-05-16 2009-11-26 Truncale Katherine G Allograft osteochondral plug combined with cartilage particle mixture
US20090149893A1 (en) * 2007-12-05 2009-06-11 Semler Eric J Cancellous Bone Implant for Cartilage Repair
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20080220044A1 (en) * 2007-03-06 2008-09-11 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
CA2717725A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US8466278B2 (en) 2008-09-22 2013-06-18 Arcarios B.V. Carboxyethylated cyclodextrin polysulfates useful as medicaments
GB0820492D0 (en) 2008-11-07 2008-12-17 Sportcell Cell compositions and uses thereof
US8637640B2 (en) * 2009-07-27 2014-01-28 Baxter International Inc. Blood coagulation protein conjugates
KR101223511B1 (ko) * 2009-10-23 2013-01-31 주식회사 알앤엘바이오 지방조직 유래 성체 줄기세포 이동을 유도하는 방법
US8687070B2 (en) * 2009-12-22 2014-04-01 Apple Inc. Image capture device having tilt and/or perspective correction
JP6382933B2 (ja) 2013-03-15 2018-08-29 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティドＷ．Ｌ． Ｇｏｒｅ ＆ Ａｓｓｏｃｉａｔｅｓ， Ｉｎｃｏｒｐｏｒａｔｅｄ 低表面エネルギー構造体用水性送達システム
US20160017046A1 (en) * 2013-03-29 2016-01-21 Merrimack Pharmaceuticals, Inc. Compositions and methods for treating osteolytic bone disorders
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN116904520B (zh) * 2023-09-13 2024-01-09 中国人民解放军军事科学院军事医学研究院 制备重组软骨祖细胞的方法及获得的重组软骨祖细胞与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413511B1 (en) * 1990-12-20 2002-07-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide
EP0804486B1 (en) * 1992-11-27 2008-10-01 Laboratoires Serono SA Granulocyte chemotactic protein
US5723331A (en) * 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
GB9502022D0 (en) * 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US6410268B1 (en) * 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
RU2142285C1 (ru) * 1997-04-14 1999-12-10 Чайлахян Рубен Карпович Способ восстановления целостности гиалинового хряща суставов
DE19814405C2 (de) * 1998-03-31 2000-03-02 Schastak Astrid Porphyrine und ihre Verwendung als Photosensitizer
US6515001B2 (en) * 2001-03-05 2003-02-04 Chemokine Therapeutic Corporation IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases
JP2005500847A (ja) * 2001-08-24 2005-01-13 アドバンスド セル テクノロジー、インコーポレイテッド 分化誘導薬の同定のためのスクリーニング検定及び細胞治療用の分化細胞の調製
EP1312614A1 (en) * 2001-11-16 2003-05-21 GenOdyssee Polynucleotides and polypeptides of the GCP-2 gene
JP2003199816A (ja) * 2002-01-10 2003-07-15 Takehisa Matsuda 軟骨組織再生用補助材、軟骨組織再生用キット及び軟骨組織再生方法
EP2298906B1 (en) * 2002-07-26 2014-01-08 Ajinomoto Co., Inc. Novel peptide-forming enzyme gene
ES2564044T3 (es) * 2003-06-27 2016-03-17 DePuy Synthes Products, Inc. Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas

Also Published As

Publication number Publication date
NO20060464L (no) 2006-04-20
CA2533124A1 (en) 2005-02-17
ATE449608T1 (de) 2009-12-15
RU2006107536A (ru) 2006-08-10
CA2533124C (en) 2014-01-28
HK1085656A1 (en) 2006-09-01
ES2337469T3 (es) 2010-04-26
US7485310B2 (en) 2009-02-03
WO2005014026A2 (en) 2005-02-17
NO338152B1 (no) 2016-08-01
IL173544A0 (en) 2006-07-05
DE602004024312D1 (de) 2010-01-07
JP2007501807A (ja) 2007-02-01
DK1653994T3 (da) 2010-03-15
EP1653994A2 (en) 2006-05-10
US20090117652A1 (en) 2009-05-07
RU2363491C2 (ru) 2009-08-10
EP1653994B1 (en) 2009-11-25
US7842502B2 (en) 2010-11-30
AU2004262451A1 (en) 2005-02-17
JP4920412B2 (ja) 2012-04-18
NZ545702A (en) 2008-08-29
WO2005014026A3 (en) 2005-03-17
US20060246031A1 (en) 2006-11-02
IL173544A (en) 2013-12-31
AU2004262451B2 (en) 2009-11-26

Similar Documents

Publication Publication Date Title
IL173544A0 (en) Use of cxcl6 chemokine in the prevention or repair of cartilage defects
GB2392674A (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
MX2009008559A (es) Hepatocitos y condorcitos de celulas madre de la placenta adherentes, y poblaciones de celulas enriquecidas con celulas madre de la placenta cd34+, cd45-.
TW200611910A (en) Interferon-alpha polypeptides and conjugates
IL190796A (en) Composition containing nucleic acid encoded by anti-osteoclastogenic protein
RS20080336A (en) Activin-actriia antagonists and uses for promoting bone growth
MXPA03000634A (es) Metodos para el reemplazo, el desplazamiento y acumulacion de adn en genomas eucarioticos.
MX2021015070A (es) Inmunomodulacion usando celulas madre de la placenta.
WO2008036374A3 (en) Allogeneic stem cell transplants in non-conditioned recipients
IL148060A0 (en) Compositions and methods for improved cell culture
IN266744B (pl)
SG152273A1 (en) Pdx1 expressing endoderm
MX2008007286A (es) Ingenieria in vivo de superficie celular.
WO2004044142A3 (en) Mesenchymal stem cells and methods of use thereof
EP2341131A3 (en) Repair and regeneration of cartilage and bone using postpartum-derived cells
MX344970B (es) Medio de cultivo celular para la expresion de la proteina adamts.
MY148759A (en) Methods to culture circovirus
DE602005015302D1 (en) Nkg2d modulation
MX2009011319A (es) Adenosina desaminasa recombinante estable.
ATE556137T1 (de) Durch einen polyelektrolytkomplex von hyaluronsäure und chitosan verstärkte biomimetische zusammensetzung
WO2005001033A3 (en) Tolerance induction and maintenance in hematopoietic stem cell allografts
EP3133150A3 (en) Derivation of embryonic stem cells and embryo-derived cells
WO2005017115A3 (en) Cord blood-derived hematopoietic progenitor cells
EP2985341A3 (en) Methods and compositions for modulating differentiation of pluripotential cells
EP1718733A4 (en) COMPOSITIONS AND METHODS FOR NEURAL STEM CELL CULTURE WITH STROMAL BONE MARROW CELLS